Kanbur, E. Et Al. 2023. The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line. European Journal of Biology , vol.82, no.1 , 49-58.

Kanbur, E., Seker, S., Budak, F., & Yerlikaya, A., (2023). The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line. European Journal of Biology , vol.82, no.1, 49-58.

Kanbur, Ertan Et Al. "The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line," European Journal of Biology , vol.82, no.1, 49-58, 2023

Kanbur, Ertan Et Al. "The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line." European Journal of Biology , vol.82, no.1, pp.49-58, 2023

Kanbur, E. Et Al. (2023) . "The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line." European Journal of Biology , vol.82, no.1, pp.49-58.

@article{article, author={Ertan Kanbur Et Al. }, title={The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line}, journal={European Journal of Biology}, year=2023, pages={49-58} }